Metastatic Liposarcoma
Also known as: Liposarcoma metastatic
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08871 | Eribulin | A microtubule inhibitor used to treat metastatic breast cancer and metastatic or unresectable liposarcoma. |
| DB05109 | Trabectedin | An alkylating agent approved for the treatment of unresectable or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma). |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00997 | Doxorubicin | 1 | Completed | 1 |
| DB11730 | Ribociclib | 1 | Completed | 1 |
| DB11945 | Avelumab | 1 / 2 | Terminated | 1 |
| DB05109 | Trabectedin | 1 / 2 | Terminated | 1 |
| DB08875 | Cabozantinib | 2 | Not Yet Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Completed | 1 |
| DB06186 | Ipilimumab | 2 | Not Yet Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Not Yet Recruiting | 1 |
| DB06589 | Pazopanib | 2 | Completed | 2 |
| DB15036 | Sitravatinib | 2 | Active Not Recruiting | 1 |
| DB01030 | Topotecan | 2 | Completed | 1 |